-
Mashup Score: 0FDA Approves RSV Drug for Children Up to 24 Months - 9 month(s) ago
AstraZeneca’s new drug, a monoclonal antibody, was given FDA approval after the Antimicrobial Drugs Advisory Committee (AMDAC) to the FDA voted in June to recommend the approval of nirsevimab (Beyfortus) for the prevention of respiratory syncytial virus (RSV) disease in infants.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0
Global pharmaceutical company AstraZeneca announced today a significant expansion of its reforestation and biodiversity-focused program, AZ Forest, including a new $400 million investment, and a commitment to plant 200 million trees by 2030. AstraZeneca launched AZ Forest in 2020, with an initial pledge to plant and maintain more than 50 million trees by the end
Categories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Current Misperception of Asthma Control - 12 month(s) ago
Health event by NMAAllergy and Chanda Nicole Holsey on Thursday, April 6 2023
Source: www.facebook.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
JOIN US TODAY for the Current Misperception of Asthma Control - April 6, streaming LIVE on NMA AAI Facebook social media channel. RSVP to this event by CLICKING HERE: https://t.co/qzBIbP8gAc. Don't miss this event! #asthmacontrol #misperceptions #health #wellness #astrazeneca https://t.co/hYO3MRjrtY
-
-
Mashup Score: 0Current Misperception of Asthma Control - 1 year(s) ago
Health event by NMAAllergy and Chanda Nicole Holsey on Thursday, April 6 2023
Source: www.facebook.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
SAVE THE DATE for the Current Misperception of Asthma Control - April 6, streaming LIVE on NMA AAI Facebook social media channel. RSVP to this event by CLICKING HERE: https://t.co/qzBIbP8gAc. Don't miss this event! #asthmacontrol #misperceptions #health #wellness #astrazeneca https://t.co/qSDNWMaBrg
-
-
Mashup Score: 0CinCor Pharma to be Acquired by AstraZeneca - 1 year(s) ago
January 9, 2023 — CinCor Pharma, Inc. announced that it has entered into a definitive agreement with AstraZeneca under which AstraZeneca has agreed to acquire CinCor. Marc de Garidel, Chief Executive Officer at CinCor, said: “We are excited about the proposed acquisition of CinCor Pharma by AstraZeneca as we believe it offers the prospect of accelerating the development timeline and expanding the…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2
Background COVID-19 vaccines have been crucial in the pandemic response and understanding changes in vaccines effectiveness is essential to guide vaccine policies. Although the Delta variant is no longer dominant, understanding vaccine effectiveness properties will provide essential knowledge to comprehend the development of the pandemic and estimate potential changes over time. Methods In this…
Source: BioMed CentralCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0
August 29, 2022 — Detailed results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) significantly reduced the composite of cardiovascular (CV) death or worsening heart failure (HF) in patients with HF and mildly reduced or preserved ejection fraction (EF), compared to placebo. The results were presented today at the European Society of Cardiology Congress 2022 in…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 4No association between messenger RNA-based COVID-19 vaccines and MI, pulmonary embolism - 2 year(s) ago
A database analysis showed no association between messenger RNA COVID-19 vaccines and risk for acute MI, stroke or pulmonary embolism, but a slight increase in risk for PE and MI after receiving the AstraZeneca or Janssen vaccines.“In a previous study, we found no increase in the rate of acute MI, stroke or PE after each dose of the Pfizer-BioNTech vaccine in persons aged 75 years or older
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Study confirms increased CVT with AstraZeneca COVID vaccine - 2 year(s) ago
“Reassuringly, no consistent association was observed between the Pfizer and Moderna mRNA vaccines and these rare complications.”
Source: www.mdedge.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2
Vikki Spit will receive £120,000 after the death of her partner Lord Zion
Source: www.gbnews.ukCategories: Hem/Oncs, Latest HeadlinesTweet
AstraZeneca's new drug, a monoclonal antibody, was given FDA approval after the Antimicrobial Drugs Advisory Committee (AMDAC) to the FDA voted in June to recommend the approval of nirsevimab (Beyfortus). https://t.co/aTUgS97M8F #RSV #astrazeneca